Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

  

Search in our Online Store
Management
Filter     Order     Display # 
Date Item Title Hits
05 Jan 2010 Biogen Idec Announces President and Chief Executive Officer James C. Mullen to Retire 482
13 Nov 2009 Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his Successor 714
15 Sep 2009 Dr. Marijn E. Dekkers to be new CEO of Bayer from October 1, 2010 706
08 Sep 2009 Roche announces new Corporate Executive Committee 374
30 Nov 2008 Chris Viehbacher takes up his position as Chief Executive Officer 1545
24 Sep 2008 PDL BioPharma Names Faheem Hasnain President and Chief Executive Officer 715
13 Sep 2008 Christine A. Poon Plans Retirement from Johnson & Johnson in Early 2009 758
09 Sep 2008 Upcoming change of Chief Executive Officer 941
25 Jul 2008 Andreas Fibig named new Chairman of the Board of Management of Bayer Schering Pharma 839
25 Jun 2008 Further steps in generation change at Boehringer Ingelheim 771
05 Feb 2008 Acorda Therapeutics Announces Acquisition of Aminopyridine and Pre-Clinical Assets from Neurorecovery, Inc. 869
18 Dec 2007 Sidney Taurel to Retire as Lilly CEO; John Lechleiter Named as Successor 840
08 Oct 2007 GlaxoSmithKline appoints Andrew Witty CEO designate 1198
02 Oct 2007 Jurgen Schwiezer named new CEO Division Roche Diagnostics 1118
11 Sep 2007 Evotec Sells its Chemical Development Business to Aptuit for GBP 31.5m (approx. EUR 46.4m; US$ 63.9m) in Cash 1113
22 Aug 2007 Pfizer names Frank A. D'Amelio Chief Financial Officer 1186
20 Aug 2007 PDL BioPharma announces internal CEO investigation found no credible evidence of improper personal conduct or breach of fiduciary duty 1105
09 Aug 2007 ImClone Systems Appoints John H. Johnson Chief Executive Officer 1154
31 Jul 2007 FDA Advisory Panel votes 22 to 1 for Avandia(R) to remain available to patients in the US 1029
 
<< Start < Prev 1 Next > End >>
Results 1 - 19 of 19

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Biologic and Immune Therapy of S. aureus Infections

Order Now

Recommended Report

RNA Therapeutics
Order Now

Subscribe La Merie Biologics